Anti-DHRS7 monoclonal antibody

Pre-made anti-DHRS7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DHRS7/DHRS7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0691-Ab-1/ GM-Tg-hg-IP0691-Ab-2Anti-Human DHRS7 monoclonal antibodyHuman
GM-Tg-rg-IP0691-Ab-1/ GM-Tg-rg-IP0691-Ab-2Anti-Rat DHRS7 monoclonal antibodyRat
GM-Tg-mg-IP0691-Ab-1/ GM-Tg-mg-IP0691-Ab-2Anti-Mouse DHRS7 monoclonal antibodyMouse
GM-Tg-cynog-IP0691-Ab-1/ GM-Tg-cynog-IP0691-Ab-2Anti-Cynomolgus/ Rhesus macaque DHRS7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0691-Ab-1/ GM-Tg-felg-IP0691-Ab-2Anti-Feline DHRS7 monoclonal antibodyFeline
GM-Tg-cang-IP0691-Ab-1/ GM-Tg-cang-IP0691-Ab-2Anti-Canine DHRS7 monoclonal antibodyCanine
GM-Tg-bovg-IP0691-Ab-1/ GM-Tg-bovg-IP0691-Ab-2Anti-Bovine DHRS7 monoclonal antibodyBovine
GM-Tg-equg-IP0691-Ab-1/ GM-Tg-equg-IP0691-Ab-2Anti-Equine DHRS7 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0691-Ab-1/ GM-Tg-hg-IP0691-Ab-2; GM-Tg-rg-IP0691-Ab-1/ GM-Tg-rg-IP0691-Ab-2;
GM-Tg-mg-IP0691-Ab-1/ GM-Tg-mg-IP0691-Ab-2; GM-Tg-cynog-IP0691-Ab-1/ GM-Tg-cynog-IP0691-Ab-2;
GM-Tg-felg-IP0691-Ab-1/ GM-Tg-felg-IP0691-Ab-2; GM-Tg-cang-IP0691-Ab-1/ GM-Tg-cang-IP0691-Ab-2;
GM-Tg-bovg-IP0691-Ab-1/ GM-Tg-bovg-IP0691-Ab-2; GM-Tg-equg-IP0691-Ab-1/ GM-Tg-equg-IP0691-Ab-2
Products NameAnti-DHRS7 monoclonal antibody
Formatmab
Target NameDHRS7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DHRS7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0691-Ag-1Recombinant multi-species DHRS7/ CGI-86/ SDR34C1 protein


    Target information

    Target IDGM-IP0691
    Target NameDHRS7
    Gene ID51635,66375,299135,702872,480342,101101227,514044,100060062
    Gene Symbol and Synonyms2310016E22Rik,5730564L20Rik,CGI-86,DHRS7,retDSR4,retSDR4,RGD1565002,SDR34C1
    Uniprot AccessionQ9Y394
    Uniprot Entry NameDHRS7_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100612
    Target ClassificationN/A

    The target: DHRS7, gene name: DHRS7, also named as CGI-86, SDR34C1, retDSR4, retSDR4. This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family, which has over 46,000 members. Members in this family are enzymes that metabolize many different compounds, such as steroid hormones, prostaglandins, retinoids, lipids and xenobiotics. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.